Cart
sales@molnova.com
NCGC00262650
CAS No. 344359-25-7
NCGC00262650( —— )
Catalog No. M24293 CAS No. 344359-25-7
NCGC00262650 is an inhibitor of AMA1-RON2 interaction and c-Src tyrosine kinase activity.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 34 | In Stock |
|
| 5MG | 29 | In Stock |
|
| 10MG | 46 | In Stock |
|
| 25MG | 75 | In Stock |
|
| 50MG | 111 | In Stock |
|
| 100MG | 164 | In Stock |
|
| 200MG | 243 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameNCGC00262650
-
NoteResearch use only, not for human use.
-
Brief DescriptionNCGC00262650 is an inhibitor of AMA1-RON2 interaction and c-Src tyrosine kinase activity.
-
DescriptionNCGC00262650 is an inhibitor of AMA1-RON2 interaction and c-Src tyrosine kinase activity.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayTyrosine Kinase
-
TargetSrc
-
RecptorAMA1-RON2|c-Src
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number344359-25-7
-
Formula Weight308.4
-
Molecular FormulaC18H20N4O
-
Purity>98% (HPLC)
-
SolubilityDMSO:10 mM
-
SMILESCOC1=CC=C(C=C1)C2=CN(C3=NC=NC(=C23)N)C4CCCC4
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Pulegone
Pulegone has cytotoxicity followed by regenerative cell proliferation is the MOA for Pulegone-induced urothelial tumors in female rats.
-
P7C3-A20
P7C3 is a drug related to latrepirdine (dimebon), which has neuroprotective and proneurogenic effects, and may be potentially useful for the treatment of Alzheimer's disease and similar neurodegenerative disorders.
-
KX2-391
KX2-391, the first clinical Src inhibitor (peptidomimetic class) that targets the peptide substrate site of Src, with GI50 of 9-60 nM in cancer cell lines.
